Luly Jay R., President and CEO of Enanta Pharmaceuticals Inc. ($ENTA), made one open market sale of company shares in the last year, totaling about $67,500. The most recent transaction occurred on December 5, 2025. This places her 10,059th among 11,678 insiders in our database ranked by sale value, well below the average of $8.6 million across 6.4 transactions per insider. She reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | F | Common Stock | 6155 | $14.25 | 871,871.0000 | 29,019,344 | 0.70% | 0.02% |
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | A | Common Stock | 15200 | $0.00 | 878,026.0000 | 29,019,344 | 1.76% | 0.05% |
| Feb. 12, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | A | Common Stock | 4800 | $0.00 | 862,826.0000 | 29,019,344 | 0.56% | 0.02% |
| Dec. 5, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | S | Common Stock | 4743 | $14.23 | 858,026.0000 | 28,862,601 | 0.55% | 0.02% |
| Dec. 1, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | F | Common Stock | 1885 | $14.12 | 862,769.0000 | 28,862,601 | 0.22% | 0.01% |
| Nov. 25, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | A | Stock Option (right to buy) | 310000 | $0.00 | 310,000.0000 | 28,862,601 | 9999.99% | 1.07% |
| Feb. 12, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | A | Common Stock | 25500 | $0.00 | 872,138.0000 | 0 | 3.01% | 0.00% |
| Feb. 12, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | F | Common Stock | 7484 | $5.59 | 864,654.0000 | 0 | 0.86% | 0.00% |
| Feb. 12, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | P | Common Stock | 45000 | $5.69 | 846,638.0000 | 0 | 5.61% | 0.00% |
| Dec. 6, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | S | Common Stock | 5142 | $8.06 | 801,638.0000 | 0 | 0.64% | 0.00% |
| Dec. 1, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | F | Common Stock | 3829 | $8.60 | 806,780.0000 | 0 | 0.47% | 0.00% |
| Nov. 27, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | F | Common Stock | 1584 | $12.41 | 810,609.0000 | 0 | 0.20% | 0.00% |
| Feb. 12, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | Luly Jay R. | President and CEO | A | Common Stock | 5400 | $0.00 | 812,193.0000 | 0 | 0.67% | 0.00% |